PerkinElmer, Inc.

686 articles with PerkinElmer, Inc.

• PerkinElmer to Present at J.P. Morgan 37th Annual Healthcare Conference

  12/21/2018

  PerkinElmer, Inc. announced that the Company will present at the J.P. Morgan 37th Annual Healthcare Conference on Wednesday, January 9, 2019, at 10:00 a.m. PT at the Westin St. Francis Hotel in San Francisco

• PerkinElmer Appoints President & Chief Operating Officer

  12/10/2018

  Promotes Prahlad Singh to lead newly created role

• PerkinElmer Receives CE-IVD Mark for Its Vanadis Fully Automated NIPT Platform

  11/26/2018

  Innovative Cost-Effective Solution Provides Pregnant Women Widespread Access to Non-Invasive Prenatal Testing

• PerkinElmer to Present at 2018 Citi Global Healthcare Conference

  11/21/2018

  PerkinElmer, Inc. today announced that the Company will present at the 2018 Citi Global Healthcare Conference on Wednesday, December 5, 2018, at 11:45 a.m. ET at the Lotte New York Palace in New York City.

• PerkinElmer to Present at Evercore ISI HealthCONx Conference

  11/15/2018

  PerkinElmer, Inc. today announced that the Company will present at the 2018 Evercore ISI HealthCONx Conference on Thursday, November 29, at 10:15 a.m. ET at the Boston Harbor Hotel.

• PerkinElmer Introduces QSight® 400 Series Triple Quad Mass Spectrometer at MJBizCon 2018

  11/14/2018

  PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its QSight® 400 Series Triple Quad Mass Spectrometer,

• Akoya Biosciences Acquires Phenoptics Portfolio from PerkinElmer

  10/31/2018

  Akoya Biosciences has acquired PerkinElmer, Inc.’s Phenoptics™ portfolio.

• PerkinElmer Announces Financial Results for the Third Quarter of 2018

  10/31/2018

  PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the third quarter ended September 30, 2018.

• PerkinElmer Board Declares Quarterly Dividend on October 24, 2018

  10/24/2018

  The Board of Directors of PerkinElmer, Inc., declared a regular quarterly dividend of $0.07 per share of common stock on October 24, 2018.

• PerkinElmer To Hold Earnings Call on Wednesday, October 31, 2018

  10/5/2018

  PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that on Wednesday, October 31, 2018, after market close, the Company will release third quarter 2018 results.

• 

  Movers and Shakers for Sept. 4

  9/4/2018

  Biopharm companies closed out August with a plethora of changes to executive and senior leadership positions. Let's take a look.

• Orchard Therapeutics Expands Leadership Team with Appointments of Head of Corporate Communications and Head of Human Resources

  8/29/2018

  Orchard Therapeutics, a leading commercial-stage company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today announced two additions to its ex­­­ecutive leadership team.

• PerkinElmer to Present at the 16th Annual Morgan Stanley Global Healthcare Conference

  8/23/2018

  PerkinElmer, Inc. today announced that the Company will present at the 16th annual Morgan Stanley Global Healthcare Conference on Friday, September 14, 2018 at 11:40 a.m. ET at the Grand Hyatt New York in New York City.

• Agena Bioscience Announces Collaboration With PerkinElmer

  8/21/2018

  Combining LabChip® GX Touch Nucleic Acid Analyzer and MassARRAY® for Optimized Liquid Biopsy Workflow

• 

  13 Massachusetts Life Science Companies Show Gains and Losses

  8/14/2018

  Massachusetts in general and Boston, specifically Cambridge, is one of the two largest centers in the U.S. for biotech startups and life science companies (the other being the San Francisco Bay Area). Here’s a look at 13 Massachusetts life science companies that are showing both gains and losses—...

• PerkinElmer Announces Financial Results for the Second Quarter of 2018

  8/1/2018

  GAAP revenue growth of 29% to $703.4 million; Core Organic revenue growth of 10%

• PerkinElmer’s EUROIMMUN Receives FDA Clearance for ANCA IFA and EUROPLUS Granulocyte Mosaic™ Assays Using EUROPattern Microscope

  7/25/2018

  Assist in Screening and Diagnosing ANCA-Associated Vasculitis

• PerkinElmer Board Declares Quarterly Dividend on July 23, 2018

  7/23/2018

  The Board of Directors of PerkinElmer, Inc. declared a regular quarterly dividend of $0.07 per share of common stock on July 23, 2018.

• PerkinElmer to Hold Earnings Call on Wednesday, August 1, 2018

  7/16/2018

  PerkinElmer, Inc. announced that on Wednesday, August 1, 2018, after market close, the Company will release second quarter 2018 results.

• PerkinElmer’s EUROIMMUN Receives 510(k) Clearance for Crithidia luciliae and Crithidia luciliae Sensitive Diagnostic Tests

  6/18/2018

  Testing Performed Together with EUROPattern System Can Help Accelerate Lupus Diagnosis